Modification of fatty acids composition in erythrocytes lipids in arterial hypertension associated with dyslipidemia

Lipids in Health and Disease

Volumn 10, Issue , 2011, Pages

  Novgorodtseva, Tatyana P ^a   Kantur, Tatyana A ^a   Karaman, Yulia K ^a   Antonyuk, Marina V ^a   Zhukova, Natalia V ^b  

^a Russian Academy of Medical Sciences   (Russian Federation)

^b INSTITUTE OF MARINE BIOLOGY   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; DOCOSAHEXAENOIC ACID; FATTY ACID; LINOLEIC ACID; LIPID; POLYUNSATURATED FATTY ACID; MEMBRANE LIPID;

ADULT; CELL MEMBRANE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DYSLIPIDEMIA; ERYTHROCYTE; FEMALE; GAS CHROMATOGRAPHY; HUMAN; HYPERTENSION; LIPID BLOOD LEVEL; LIPID COMPOSITION; LIPID METABOLISM; MALE; REVIEW; ARTICLE; BLOOD; CASE CONTROL STUDY; CHEMISTRY; METABOLISM; MIDDLE AGED;

CASE-CONTROL STUDIES; DYSLIPIDEMIAS; ERYTHROCYTES; FATTY ACIDS; FEMALE; HUMANS; HYPERTENSION; LIPIDS; MEMBRANE LIPIDS; MIDDLE AGED;

EID: 78651544667     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-10-18     Document Type: Review

References (30)

1. Svetashev VI Modification of blood fatty acids composition in case of cardiovascular diseases. EA Endakova TP Novgorodtseva, Vladivostok: Dalnauka 2002 296
2. Atherosclerosis as a pathology polien fatty acids. VN Titov, Biological bases pathogenesis, diagnostics, preventive and treatment of atherosclerosis. M: Altus 2002 750
3. Hypertension and appraisal of the overall cardiovascular risk: results of epidemiological monitoring of hypertension. SA Shalnova AD Deev VV Konstantinov RG Oganov, Consillium Medicum 2007 11 31 35
4. Change the liver in insulin resistance. LA Zvenigorodskaya SG Homeric EG Egorova, Hard patient 2008 6 5-6 71 74
5. Essential hypertension: causes, mechanisms, clinical features, treatment. MS Kuszakowski, St. Petersburg: Pholiant 2002 416
6. Dyslipidemia and the risk of incident hypertension in men. RO Halperin HD Sesso J Ma JE Buring MJ Stampfer (Pubitemid 43177814)
7. The association between lipid levels and the risks of incident myocardial infarction, stroke, and total mortality: The Cardiovascular Health Study. BM Psaty M Anderson RA Kronmal RP Tracy T Orchard LP Fried T Lumley J Robbins G Burke AB Newman CD Furberg, Arch Intern Med 2005 165 2420 2427 10.1001/archinte.165.20.2420 16287773
8. Results of multicenter study to identify giperholeste rinemii-based analysis of regional centers of lipid. VN Kovalenko EI Mitchenko VY Romanov O Kulik AA Logvinenko MF Gelmedova, Ukr cardiology J 2008 8 68 78
9. A Prospective Study of Plasma Lipid Levels and Hypertension in Women. HD Sesso JE Buring MJ Chown PM Ridker JM Gaziano, Arch Intern Med 2005 165 2420 2427 10.1001/archinte.165.20.2420 16287773 (Pubitemid 41640856)
10. Ethnic and Sex Differences in the Prevalence, Treatment, and Control of Dyslipidemia Among Hypertensive Adults in the GENOA Study. JG O'Meara LR Sharon JJ Armon CA Brown E Boerwinkle ST Turner, Arch Intern Med 2004 164 1313 1318 15226165 (Pubitemid 38828882)
11. Twenty-year trends in serum cholesterol, hypercholesterinemia and cholesterol medication use. The Minnesota Heart Survey, 1980-1982 to 200-2002. DK Arnett DR Jacobs RV Luepker H Blackburn C Armstrong SA Claas, Circulation 2005 112 3884 3491 10.1161/CIRCULATIONAHA.105.549857 16344385
12. Dyslipidemia Prevalence, Treatment, and Control in the Multi-Ethnic Study of Atherosclerosis (MESA). DC Goff AG Bertoni H Kramer D Bonds RS Blumenthal MY Tsai BM Psaty, Circulation 2006 113 647 656 10.1161/CIRCULATIONAHA.105.552737 16461837
13. Cholesterol and mortality: 30 years of follow-up from the Framingham Study. KM Anderson WP Castelli DB Levy, JAMA 1987 257 2176 2180 10.1001/jama.257.16.2176 3560398 (Pubitemid 17055840)
14. Correction of lipid disorders in patients with arterial hypertension. AA Liakishev, Rus med J 2002 10 19 878 882
15. Hypercholesterolemia and arterial hypertension. JD Kobalava VV Tolkachev, Heart 2006 4 28 172 176
16. Treatment of lipid disorders in patients with coronary heart disease. SY Martsevich, reating physician 2005 5 42 45
17. The experience of the drug Cordon patients with arterial hypertension and dyslipidemia. EI Mitchenko VY Romanov, Ukr med J 2007 5 61 73 77
18. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participant in 14 randomised trials of statins. C Baigent A Keech PM Kearney L Blackwell G Buck C Pollicino A Kirby T Sourjina R Peto R Collins R Simes, Lancet 2005 366 1267 1278 10.1016/S0140-6736(05)67394-1 16214597
19. Incidence of hospitalized rhabdomyolysis in patients treated with lipid-lowering drugs. DJ Graham JA Staffa D Shatin SE Andrade SD Schech L La Grenade JH Gurwitz KA Chan MJ Goodman R Platt, JAMA 2004 292 2585 2590 10.1001/jama.292.21.2585 15572716 (Pubitemid 39577514)
20. Guidelines for the Management of Arterial Hypertension: the task force for the Management of Arterial Hypertension of the Europen Society of Hypertension (ESH) and Europen Society of Cardiology (ESC). G Mancia G De Backer A Dominiczak R Cifkova R Fagard G Germano G Grassi AM Heagerty SE Kjeldsen S Laurent K Narkiewicz L Ruilope A Rynkiewicz RE Schmieder HA Struijker Boudier A Zanchetti, J Hypertens 2007 25 1105 1187 2007 10.1097/HJH.0b013e3281fc975a 17563527 (Pubitemid 46924065)
21. Exchange of lipids and lipoproteins and its on-fracture: a guide for physicians. AN Klimov NG Nikulicheva, St. Petersburg: Peter Com 1999 512
22. A rapid method of total lipid extraction and purification. EG Bligh WJ Dyer, Can J Biochem Physiol 1959 37 911 917 13671378
23. Adaptation of a macroscale method to the microscale for fatty acid methyl transesterification of biological lipid extract. JP Carreau JP Duback, J Chromatogr 1978 151 384 390 10.1016/S0021-9673(00)88356-9 (Pubitemid 8343999)
24. An improved method of characterizing fatty acids by equivalent chain length values. K Stransky T Jursik A Vitek J Skorepa, J High Res Chromatogr 1992 15 730 740 10.1002/jhrc.1240151107
25. GLC identification techniques for long - chain unsaturated fatty acids. GR Jamieson, J Chromatogr Sci 1975 13 491 497 1184716
26. Mathematical Statistics in Medicine. VA Medic MS Tokmachev, Moscow: Finances and Statistics 2007 798
27. Violation of transport in cells of saturated fatty acids in the pathogenesis of essential hypertension. VN Titov, Question med chemistry 1998 44 4 317 330
28. The effect of high fat food on erythrocyte phospholipids, fatty acids composition and glutathione redox-system of rats with alimentary dyslipidemia. TP Novgorodtseva YK Karaman NV Zhukova, The Health 2010 2 1 45 50 10.4236/health.2010.21008
29. Metabolic indicators and struktura membranes erythrocytes at obesity and a metabolic syndrome at women. VV Potyomkin SJ Troitskaja AG Maksina, Russ Med J 2006 1 35 38
30. The role of free and esterified fatty acids in pathogenesis of metabolic syndrome. TP Novgorodtseva YK Karaman MV Antoniuk NV Zhukova, Klin Med 2009 7 5 33 37